V
VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
HKEX:1873
Price:
0.62 HKD
1.64%
Market Closed
Updated:
May 3, 2024
VIVA Biotech Holdings
Cash from Financing Activities
|
VIVA Biotech Holdings
Cash from Financing Activities Peer Comparison
Comparables:
603259
300759
2269
300347
M
688114
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Cash from Financing Activities
-¥143.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Financing Activities
¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Financing Activities
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Financing Activities
-¥7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Cash from Financing Activities
¥3.3B
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Cash from Financing Activities?
Cash from Financing Activities
-143.2m
CNY
-143.2m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Cash from Financing Activities amounts to -143.2m CNY.
What is VIVA Biotech Holdings's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
0%
0%
Over the last year, the Cash from Financing Activities growth was 0%.
You don't have any saved screeners yet
